Hospital readmission after transvenous cardioverter/defibrillator implantation -: A single centre study
Hospital readmission after transvenous cardioverter/defibrillator implantation -: A single centre study
复制标题
DOI：
10.1053/euhj.1999.2044
复制
发表时间：
2000-07-01
影响因子：
39.3
通讯作者：
Lüderitz, B
中科院分区：
文献类型：
--
作者：
Korte, T;Jung, W;Lüderitz, B
植入心脏复律器/除颤器后再次入院对除颤器患者的生活质量和成本效益有重大影响。再住院没有研究在大型患者人群与现代transvenous除颤systems.Methods和结果的发病率，原因，时间在后续的持续时间和预测因素，在180例患者的心脏复律器/除颤器植入后，在25 +/- 18个月的随访期内再次入院。79例患者中有156例再入院，随访期间每例患者的再入院率为0.87，随访期间每例患者年的再入院率为0.46，随访期间每例患者年因心脏原因的再入院率为0.38。大多数再入院是由多次适当的电击干预（26%）、电池耗尽（19%）以及电极导线和器械相关并发症（14%）引起的。首次再入院时间，与心血管相关的为12 +/- 9个月，与其他心脏相关的为20 +/- 16个月（P < 0.05）。
Aims Hospital readmission after implantation of cardioverter/defibrillators has a major impact on quality of life and cost-effectiveness in defibrillator patients. Rehospitalization has not been studied in large patient populations with modern transvenous defibrillation systems.Methods and Results We report on incidence, reasons, time in follow-up duration and predictors of hospital readmission in 180 patients after transvenous implantation of a cardioverter/defibrillator during a follow-up period of 25 +/- 18 months. There were 156 readmissions in 79 patients with a 0.87 readmission rate per patient during the time followed, a 0.46 readmission rate per patient-year of follow-up and a 0.38 readmission rate per patient-year of follow-up for cardiac reasons. The majority of readmissions was caused by multiple appropriate shock interventions (26%), battery depletion (19%) and lead- and device-related complications (14%). The time to first hospital readmission was 12 +/- 9 months for arrhythmia-related and 20 +/- 16 months for other cardiac-related reasons (P60 years was an independent predictor of rehospitalization time per patient-year of follow-up for both cardiac-related (P